Zuzanna Brzosko

Life Sciences sector:
(1) Neuroscience: PhD and postdoc in Physiology, Development and Neuroscience at Cambridge University – c. 5.5 years; published papers/review in e.g. eLife and Neuron.
(2) Drug Delivery/ Nanotechnology / Oncology / Therapeutics / Biotech: CEO of Sixfold Biosciene (since 2017) – a biotechnology company focused on developing nanotechnology-based delivery systems for Cell and Gene therapeutics. Focus on oncology applications. Experience as EU Pharma and Biotech equity research analyst at Goldman Sachs focused on analysing European pharma and biotech companies.

Business financing:
Funding sources/fundraising: successfuly raised angel/VC dilutive funding (multi-million dollar) and grant funding (Innovate UK, Horizon 2020, London Advanced Therapies) for Sixfold Bioscience
Seed funding/venture capital: alumna of the world’s best known accelerator (Y Combinator in Silicon Valley – Winter 2018) – raised funding from VCs for Sixfold Bioscience. Forbes 30 under 30 EU Healthcare 2018, Maseratti’s and The Sunday Times 100 top UK Entrepreneurs 2019, Rising Star in 50 Movers and Shakers in Biobusiness 2018.